Wang Jinguo, Ma Haichun, Zhou Honglan, Gao Yang, Fu Yaowen, Wang Na
Department of Anesthesiology, First Hospital of Jilin University, China.
Anaesthesiol Intensive Ther. 2016;48(5):300-304. doi: 10.5603/AIT.a2016.0052. Epub 2016 Nov 11.
The aim of this study was to evaluate the efficacy of preoperative intravenous oxycodone administration on postoperative sufentanil consumption in patients undergoing retroperitoneal laparoscopic nephrectomy.
Fifty patients scheduled for retroperitoneal laparoscopic nephrectomy were enrolled and randomly assigned to two groups- patients in Group O (n = 25) received intravenously 0.1 mg kg⁻¹ oxycodone; while the patients in Group C (n = 25) received 0.1 mL kg⁻¹ normal saline for 2 min, 10 min before the operation. All of the participants received intravenous sufentanil patient-controlled analgesia (PCA) after extubation, using a PCA device. The sufentanil consumption, rescue analgesia, Ramsay sedation scale (RSS) and visual analogue scale (VAS) scores at rest and during cough, the overall satisfaction and undesired events were all assessed.
Cumulative sufentanil consumption delivered by PCA was significantly lower in Group O at all time points. VAS scores at rest and during coughing at 1, 2, 4, 8 and 12 hours after extubation of the patient were significantly lower in Group O than in Group C. There were no significant differences between the two groups according to the number of patients administered tramadol, RSS and the incidence of side effects. The degree of patients' satisfaction was higher in Group O.
Preoperative intravenous oxycodone can reduce postoperative cumulative sufentanil consumption and postoperative pain intensity without an increase in side effects.
本研究旨在评估术前静脉注射羟考酮对接受后腹腔镜肾切除术患者术后舒芬太尼用量的影响。
选取50例计划行后腹腔镜肾切除术的患者,随机分为两组。O组(n = 25)患者在术前10分钟静脉注射0.1 mg·kg⁻¹羟考酮;C组(n = 25)患者在术前10分钟静脉注射0.1 mL·kg⁻¹生理盐水,持续2分钟。所有患者拔管后均使用患者自控镇痛(PCA)泵静脉注射舒芬太尼。评估舒芬太尼用量、补救性镇痛、Ramsay镇静评分(RSS)、静息和咳嗽时的视觉模拟评分(VAS)、总体满意度及不良事件。
O组PCA泵输注的舒芬太尼累计用量在各时间点均显著低于C组。患者拔管后1、2、4、8和12小时静息及咳嗽时的VAS评分,O组显著低于C组。两组间曲马多使用患者数量、RSS及副作用发生率无显著差异。O组患者满意度更高。
术前静脉注射羟考酮可减少术后舒芬太尼累计用量及术后疼痛强度,且不增加副作用。